Cigna seeks to disqualify FTC Chair Lina Khan from insulin case because of alleged bias
Cigna said that Khan, along with Commissioners Rebecca Kelly Slaughter and Alvaro Bedoya, have made repeated and incorrect prejudgments that show bias against pharmacy-benefit managers.
CVS, Cigna Seek to Disqualify FTC Officials in Insulin Case Over Alleged Bias
The healthcare company said Chair Lina Khan, Commissioner Rebecca Kelly Slaughter and Commissioner Alvaro Bedoya through public statements show they have prejudged the matter at hand.
Major PBMs ask judge to remove Lina Khan from FTC’s insulin-price lawsuit
UnitedHealth, CVS Health, and Cigna have petitioned a judge to sideline FTC Chair Lina Khan from the agency’s lawsuit against the largest PBMs
CVS, Cigna, UnitedHealth press for FTC Chair Khan to be removed from PBM lawsuit
Cigna, UnitedHealth and CVS Caremark are calling Federal Trade Commission (FTC) Chair Lina Khan and two other commissioners to either recuse themselves, or be removed from the agency’s lawsuit
CVS, UnitedHealth, Cigna Ask FTC's Khan to Disqualify Herself From Insulin Case
NEW YORK (Reuters) -CVS Health, UnitedHealth Group and Cigna have asked U.S. Federal Trade Commission chair Lina Khan and commissioners Rebecca Kelly Slaughter and Alvaro Bedoya to disqualify themselves from an FTC lawsuit that has accused the companies of unlawfully inflating insulin prices.
Healthcare Firms Call FTC’s Khan Biased. They Want Her Off the Insulin Case.
The agency has filed an administrative complaint accusing pharmacy benefit managers of artificially inflating the price of insulin.
WSHU news2h
Cigna customers at risk of losing Hartford Healthcare coverage if contract not renewed
Cigna policyholders may have to pay out-of-network rates for Hartford Healthcare services if the companies can’t reach an ...
Cigna policyholders could lose coverage for Hartford HealthCare if deal not struck by Nov. 1
Cigna policyholders could lose coverage for Hartford HealthCare services if a contract renewal is not negotiated by Nov. 1.
bovnews19h
What’s Causing Cigna Group (CI) Stock’s 0.73% Jump Over the Last Six Months?
On Monday, Cigna Group (CI) stock saw a modest uptick, ending the day at $351.45 which represents a slight increase of $1.15 or 0.33% from the prior close of $350.3. The stock opened at $350.13 and ...
Hartford Business4d
Three years after $10.4M sale, 682,000-sq-ft former Cigna HQ in Bloomfield on the market again
A little less than three years after New York investors paid $10.45 million for Cigna’s former global headquarters in ...
Cigna Group stock underperforms Thursday when compared to competitors despite daily gains
This was the stock's third consecutive day of gains.
bovnews4d
Cigna Group (CI) Stock Dilemma: A Drop That Has Everyone Talking—What’s the Real Story?
On Friday, Cigna Group (CI) stock saw a decline, ending the day at $350.3 which represents a decrease of $-0.20 or -0.06% from the prior close of $350.5. The stock opened at $351.37 and touched a low ...
thetechedvocate.org5d
Drug Rehab That Accepts Cigna
Spread the loveSeeking treatment for drug addiction is a crucial step towards recovery, and having insurance coverage can ...
MarketWatch18h
Cigna Group stock outperforms competitors despite losses on the day
Shares of Cigna Group CI shed 0.74% to $348.84 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index SPX falling 0.76% to 5,815.26 and Dow ...